levodopa has been researched along with yohimbine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kent, S | 1 |
| Dinari, G; Kiro, A; Marcus, H; Zahavi, I | 1 |
| Männistö, PT; Törnwall, M | 1 |
| Berlan, M; Durrieu, G; Montastruc, JL; Valet, P; Villeneuve, A | 1 |
| Berlan, M; Boneu, B; Caranobe, C; Lafontan, M; Montastruc, JL; Rascol, A; Villeneuve, A | 1 |
| Ohno, Y; Sasa, M; Takaori, S; Yoshida, O; Yoshimura, N | 1 |
| Jacobs, BL; Morilak, DA | 1 |
| Antonaccio, MJ; Robson, RD | 1 |
| Lapin, IP | 1 |
| Henning, M; Hermansson, LE; Johansson, P | 1 |
| Ikoma, H; Kikumoto, R; Tobe, A; Tonomura, S; Yoshida, Y | 1 |
| Goshima, Y; Misu, Y; Miyamae, T; Okumura, F; Sato, K | 1 |
| Bédard, PJ; Gomez-Mancilla, B | 1 |
| Brotchie, JM; Crossman, AR; Henry, B | 1 |
| Brotchie, JM; Crossman, AR; Fox, SH; Henry, B; Peggs, D | 1 |
| Archer, T; Fredriksson, A | 1 |
| Afonso, J; Moura, E; Pinto, CE; Serrão, MP; Vieira-Coelho, MA | 1 |
| Fitzgerald, PJ; Maren, S; Seemann, JR | 1 |
1 review(s) available for levodopa and yohimbine
| Article | Year |
|---|---|
Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Topics: Animals; Conditioning, Classical; Extinction, Psychological; Fear; Fluoxetine; Humans; Levodopa; Neurotransmitter Agents; Propranolol; Yohimbine | 2014 |
18 other study(ies) available for levodopa and yohimbine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
On the trail of an authentic aphrodisiac.
Topics: Animals; Aphrodisiacs; Brain; Cantharidin; Cricetinae; Electric Stimulation; Female; Fenclonine; Humans; Levodopa; Male; Mice; Pheromones; Rabbits; Rats; Sexual Behavior; Yohimbine | 1975 |
L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism.
Topics: Animals; Clonidine; Haloperidol; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Ulcer; Yohimbine | 1992 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
Levodopa up-regulates platelet alpha 2-adrenoceptors.
Topics: Animals; Binding, Competitive; Blood Platelets; Catecholamines; Cell Membrane; Dogs; Dopamine; Female; Levodopa; Male; Receptors, Adrenergic, alpha; Up-Regulation; Yohimbine | 1990 |
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
Topics: Aged; Blood Platelets; Bromocriptine; Cell Membrane; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine | 1985 |
Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus.
Topics: Animals; Cats; Electric Stimulation; Hypogastric Plexus; Levodopa; Locus Coeruleus; Muscle Contraction; Norepinephrine; Phentolamine; Prazosin; Pressure; Reserpine; Sotalol; Urinary Bladder; Yohimbine | 1988 |
Noradrenergic modulation of sensorimotor processes in intact rats: the masseteric reflex as a model system.
Topics: Animals; Clonidine; Levodopa; Male; Masseter Muscle; Masticatory Muscles; Norepinephrine; Rats; Rats, Inbred Strains; Reflex; Yohimbine | 1985 |
L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Brain Chemistry; Carbidopa; Chlorpromazine; Depression, Chemical; Dogs; Drug Interactions; Female; Fenclonine; Haloperidol; Heart Rate; Levodopa; Male; Methysergide; Monoamine Oxidase Inhibitors; Norepinephrine; Reserpine; Serotonin; Time Factors; Yohimbine | 1974 |
Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs.
Topics: Animals; Antidepressive Agents; Drug Synergism; Female; Levodopa; Male; Mice; Serotonin; Social Isolation; Sympathetic Nervous System; Sympatholytics; Yohimbine | 1980 |
Mediation and mechanisms of the hypotensive effect of L-dopa in the sea-gull: Larus argentatus.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Birds; Blood Pressure; Heart Rate; Levodopa; Prazosin; Receptors, Dopamine; Time Factors; Vagotomy; Yohimbine | 1983 |
Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Topics: Aggression; Animals; Antidepressive Agents; Behavior, Animal; Benzhydryl Compounds; Catalepsy; Catecholamines; Cats; Drug Interactions; Female; Humans; Levodopa; Male; Methamphetamine; Mice; Parasympatholytics; Rats; Reserpine; Stereotyped Behavior; Tetrabenazine; Yohimbine | 1981 |
L-dopa potentiates presynaptic inhibitory alpha 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Brimonidine Tartrate; Hypothalamus; In Vitro Techniques; Levodopa; Male; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Synapses; Yohimbine | 1993 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Antagonists; Animals; Antiparkinson Agents; Brain; Callithrix; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesias; Female; Idazoxan; Levodopa; Male; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 1999 |
An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Clonidine; Dopamine; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Guanfacine; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurons; Parkinsonian Disorders; Prazosin; Receptors, Adrenergic, alpha-2; Synaptic Transmission; Yohimbine | 2003 |
Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.
Topics: Acridines; Adrenergic alpha-2 Receptor Antagonists; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biological Transport; Brain; Catechol O-Methyltransferase; Catecholamines; Cell Line, Tumor; Dopamine beta-Hydroxylase; Humans; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; Piperazines; Receptors, Adrenergic, alpha-2; Tyrosine 3-Monooxygenase; Yohimbine | 2009 |